271 related articles for article (PubMed ID: 28543830)
1. Weight change, obesity and risk of prostate cancer progression among men with clinically localized prostate cancer.
Dickerman BA; Ahearn TU; Giovannucci E; Stampfer MJ; Nguyen PL; Mucci LA; Wilson KM
Int J Cancer; 2017 Sep; 141(5):933-944. PubMed ID: 28543830
[TBL] [Abstract][Full Text] [Related]
2. Body mass index and weight change in men with prostate cancer: progression and mortality.
Bonn SE; Wiklund F; Sjölander A; Szulkin R; Stattin P; Holmberg E; Grönberg H; Bälter K
Cancer Causes Control; 2014 Aug; 25(8):933-43. PubMed ID: 24810654
[TBL] [Abstract][Full Text] [Related]
3. Body mass index trajectories across adulthood and smoking in relation to prostate cancer risks: the NIH-AARP Diet and Health Study.
Kelly SP; Lennon H; Sperrin M; Matthews C; Freedman ND; Albanes D; Leitzmann MF; Renehan AG; Cook MB
Int J Epidemiol; 2019 Apr; 48(2):464-473. PubMed ID: 30376043
[TBL] [Abstract][Full Text] [Related]
4. Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men.
Gong Z; Agalliu I; Lin DW; Stanford JL; Kristal AR
Cancer; 2007 Mar; 109(6):1192-202. PubMed ID: 17311344
[TBL] [Abstract][Full Text] [Related]
5. Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy.
Strom SS; Wang X; Pettaway CA; Logothetis CJ; Yamamura Y; Do KA; Babaian RJ; Troncoso P
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6889-94. PubMed ID: 16203779
[TBL] [Abstract][Full Text] [Related]
6. The association of weight change in young adulthood and smoking status with risk of prostate cancer recurrence.
Khan S; Hicks V; Colditz GA; Kibel AS; Drake BF
Int J Cancer; 2018 May; 142(10):2011-2018. PubMed ID: 29270988
[TBL] [Abstract][Full Text] [Related]
7. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
Rodriguez C; Freedland SJ; Deka A; Jacobs EJ; McCullough ML; Patel AV; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):63-9. PubMed ID: 17179486
[TBL] [Abstract][Full Text] [Related]
8. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis.
Ma J; Li H; Giovannucci E; Mucci L; Qiu W; Nguyen PL; Gaziano JM; Pollak M; Stampfer MJ
Lancet Oncol; 2008 Nov; 9(11):1039-47. PubMed ID: 18835745
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality.
Wright ME; Chang SC; Schatzkin A; Albanes D; Kipnis V; Mouw T; Hurwitz P; Hollenbeck A; Leitzmann MF
Cancer; 2007 Feb; 109(4):675-84. PubMed ID: 17211863
[TBL] [Abstract][Full Text] [Related]
10. Obesity is associated with risk of progression for low-risk prostate cancers managed expectantly.
Bhindi B; Kulkarni GS; Finelli A; Alibhai SM; Hamilton RJ; Toi A; van der Kwast TH; Evans A; Hersey K; Jewett MA; Zlotta AR; Trachtenberg J; Fleshner NE
Eur Urol; 2014 Nov; 66(5):841-8. PubMed ID: 24954793
[TBL] [Abstract][Full Text] [Related]
11. Obesity and long-term survival after radical prostatectomy.
Chalfin HJ; Lee SB; Jeong BC; Freedland SJ; Alai H; Feng Z; Trock BJ; Partin AW; Humphreys E; Walsh PC; Han M
J Urol; 2014 Oct; 192(4):1100-4. PubMed ID: 24769031
[TBL] [Abstract][Full Text] [Related]
12. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
13. Obesity and prostate enlargement in men with localized prostate cancer.
Kopp RP; Han M; Partin AW; Humphreys E; Freedland SJ; Parsons JK
BJU Int; 2011 Dec; 108(11):1750-5. PubMed ID: 21736693
[TBL] [Abstract][Full Text] [Related]
14. Weight change and prostate cancer incidence and mortality.
Bassett JK; Severi G; Baglietto L; MacInnis RJ; Hoang HN; Hopper JL; English DR; Giles GG
Int J Cancer; 2012 Oct; 131(7):1711-9. PubMed ID: 22213024
[TBL] [Abstract][Full Text] [Related]
15. Body size across the life course and prostate cancer in the Health Professionals Follow-up Study.
Möller E; Wilson KM; Batista JL; Mucci LA; Bälter K; Giovannucci E
Int J Cancer; 2016 Feb; 138(4):853-65. PubMed ID: 26355806
[TBL] [Abstract][Full Text] [Related]
16. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
[TBL] [Abstract][Full Text] [Related]
17. Body mass index in relation to serum prostate-specific antigen levels and prostate cancer risk.
Bonn SE; Sjölander A; Tillander A; Wiklund F; Grönberg H; Bälter K
Int J Cancer; 2016 Jul; 139(1):50-7. PubMed ID: 26914149
[TBL] [Abstract][Full Text] [Related]
18. Postdiagnosis Body Mass Index, Weight Change, and Mortality From Prostate Cancer, Cardiovascular Disease, and All Causes Among Survivors of Nonmetastatic Prostate Cancer.
Troeschel AN; Hartman TJ; Jacobs EJ; Stevens VL; Gansler T; Flanders WD; McCullough LE; Wang Y
J Clin Oncol; 2020 Jun; 38(18):2018-2027. PubMed ID: 32250715
[TBL] [Abstract][Full Text] [Related]
19. Body mass index and weight change in relation to triple-negative breast cancer survival.
Bao PP; Cai H; Peng P; Gu K; Su Y; Shu XO; Zheng Y
Cancer Causes Control; 2016 Feb; 27(2):229-36. PubMed ID: 26621544
[TBL] [Abstract][Full Text] [Related]
20. The ratio of oleic-to-stearic acid in the prostate predicts biochemical failure after radical prostatectomy for localized prostate cancer.
Kositsawat J; Flanigan RC; Meydani M; Choi YK; Freeman VL
J Urol; 2007 Dec; 178(6):2391-6; discussion 2396. PubMed ID: 17936811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
